Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 May;69(5):1054-1066. doi: 10.1002/art.40034. Epub 2017 Apr 6.

2.

Do vaccinations affect the clinical course of systemic necrotising vasculitis? A prospective observational web-based study.

Kernéis S, Turbelin C, Pagnoux C, Launay O, Mahr AD, Guillevin L, Boëlle PY, Hanslik T.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S89-92. Epub 2016 May 19.

PMID:
27214210
3.

Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides.

Charles P, Bienvenu B, Bonnotte B, Gobert P, Godmer P, Hachulla É, Hamidou M, Harlé JR, Karras A, Lega JC, Le Quellec A, Mahr AD, Mouthon L, Papo T, Puéchal X, Pugnet G, Samson M, Sibilia J, Terrier B, Vandergheynst F, Guillevin L; French Vasculitis Study Group.

Presse Med. 2013 Oct;42(10):1317-30. doi: 10.1016/j.lpm.2013.08.003. Epub 2013 Oct 2.

PMID:
24095054
4.

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.

Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, Carrington K, Zhang SS, Pulit SL, Ripke S, Carette S, Dellaripa PF, Edberg JC, Hoffman GS, Khalidi N, Langford CA, Mahr AD, St Clair EW, Seo P, Specks U, Spiera RF, Stone JH, Ytterberg SR, Raychaudhuri S, de Bakker PI, Farrer LA, Amos CI, Merkel PA, Siminovitch KA.

Arthritis Rheum. 2013 Sep;65(9):2457-68. doi: 10.1002/art.38036.

5.

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA.

Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715. No abstract available.

6.

Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis.

Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M, Dellaripa PF, Hoffman GS, Mahr AD, Seo P, Specks U, Spiera RF, St Clair EW, Stone JH, Plenge RM, Siminovitch KA, Merkel PA, Monach PA.

Arthritis Rheum. 2012 Oct;64(10):3463-71. doi: 10.1002/art.34496.

7.

IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, Kimberly RP.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20736-41. doi: 10.1073/pnas.1109227109. Epub 2011 Dec 6.

8.

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA.

Rheumatology (Oxford). 2012 Jan;51(1):100-9. doi: 10.1093/rheumatology/ker280. Epub 2011 Oct 29.

9.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA; American College of Rheumatology; American Society of Nephrology; European League Against Rheumatism.

Arthritis Rheum. 2011 Apr;63(4):863-4. doi: 10.1002/art.30286. No abstract available.

10.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R.

J Am Soc Nephrol. 2011 Apr;22(4):587-8. doi: 10.1681/ASN.2011010081. Epub 2011 Mar 3. No abstract available.

11.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R.

Ann Rheum Dis. 2011 Apr;70(4):704. doi: 10.1136/ard.2011.150714. No abstract available.

PMID:
21372195
12.

Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.

Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, Dellaripa PF, Seo P, Spiera RF, Rouhani FN, Brantly ML, Merkel PA.

Arthritis Rheum. 2010 Dec;62(12):3760-7. doi: 10.1002/art.27742.

13.

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.

Merkel PA, Herlyn K, Mahr AD, Neogi T, Seo P, Walsh M, Boers M, Luqmani R.

J Rheumatol. 2009 Oct;36(10):2362-8. doi: 10.3899/jrheum.090373.

14.
15.

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Merkel PA, Cuthbertson DD, Hellmich B, Hoffman GS, Jayne DR, Kallenberg CG, Krischer JP, Luqmani R, Mahr AD, Matteson EL, Specks U, Stone JH; Vasculitis Clinical Research Consortium.

Ann Rheum Dis. 2009 Jan;68(1):103-6. doi: 10.1136/ard.2008.097758. Epub 2008 Jul 29.

16.

Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.

Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA; Wegener's Granulomatosis Etanercept Trial Research Group.

Arthritis Rheum. 2008 Jun 15;59(6):884-91. doi: 10.1002/art.23707.

17.

Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.

de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW, Mahr AD, Niles JL, de Heer E, Bruijn JA, Bajema IM.

Clin J Am Soc Nephrol. 2008 Jan;3(1):237-52. Epub 2007 Dec 12. Review.

18.

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.

Arthritis Rheum. 2007 Aug;56(8):2789-97.

19.

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M.

Rheumatology (Oxford). 2007 Aug;46(8):1329-37. Epub 2007 Jun 6.

PMID:
17553910
20.

Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.

Sebastian JK, Mahr AD, Ahmed SS, Stone JH, Romay-Penabad Z, Davis JC, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Pierangeli S, Merkel PA.

J Rheumatol. 2007 May;34(5):1027-31. Epub 2007 Apr 15.

PMID:
17444585
21.

Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants.

Mahr AD, Neogi T, Merkel PA.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S82-91. Review.

PMID:
16859601

Supplemental Content

Support Center